Specialized Medical Company vs DaVita Inc.
A head-to-head of Specialized Medical Company (4019) and DaVita Inc. (DVA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4019 | DVA |
|---|---|---|
| Market Cap | 4.18B SAR | $15.21B |
| P/E (TTM) | 15.09 | 21.98 |
| Forward P/E | 15.21 | 11.63 |
| P/S | 2.70 | 0.91 |
| P/B | 3.93 | 15.64 |
| EV/EBITDA | 16.36 | 8.90 |
| Dividend Yield | 1.91% | — |
| Profit Margin | 17.36% | 5.65% |
| Gross Margin | 24.89% | 32.25% |
| Operating Margin | 15.82% | 14.74% |
| Revenue Growth (YoY) | +3.19% | +5.96% |
| FCF Yield | 4.78% | 12.00% |
| Debt / Equity | 52.90 | 1013.79 |
| Current Ratio | 1.10 | 1.42 |
Which is better: Specialized Medical Company or DaVita Inc.?
- ✓Larger by market cap: DaVita Inc.
- ✓Cheaper valuation (lower P/E): Specialized Medical Company
- ✓More profitable (net margin): Specialized Medical Company
- ✓Faster revenue growth: DaVita Inc.
- ✓Higher free-cash-flow yield: DaVita Inc.
Across 12 available metrics, DaVita Inc. leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Specialized Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.